Loading clinical trials...
Loading clinical trials...
The purpose of this research study is to explore the mechanism of action of Mucinex, an oral, over-the-counter, FDA approved expectorant in patients with acute respiratory tract infections.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Reckitt Benckiser LLC
NCT07396428 · Acute Respiratory Infection, Influenza-like Illness
NCT07278700 · Acute Respiratory Infections, Febrile Illnesses, and more
NCT07211997 · Acute Respiratory Infections (ARIs)
NCT05814237 · Acute Respiratory Infection, Acute Respiratory Tract Infection
NCT04099082 · Allogeneic Hematopoietic Stem Cell Recipients, Acute Respiratory Infection, and more
Center for Environmental Medicine, Asthma, and Lung Biology
Chapel Hill, North Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions